help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by PRATICÒ, D.
Right arrow Articles by FITZGERALD, G. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by PRATICÒ, D.
Right arrow Articles by FITZGERALD, G. A.

Am. J. Respir. Crit. Care Med., Volume 158, Number 6, December 1998, 1709-1714

Chronic Obstructive Pulmonary Disease Is Associated with an Increase in Urinary Levels of Isoprostane F2alpha -III, an Index of Oxidant Stress

DOMENICO PRATICÒ, STEFANIA BASILI, MARIO VIERI, CORRADO CORDOVA, FRANCESCO VIOLI, and GARRET A. FITZGERALD

Center for Experimental Therapeutics, University of Pennsylvania, Philadelphia, Pennsylvania; and Department of Internal Medicine, I Clinica Medica, and Terapia Medica Sistematica, University of Rome "La Sapienza," Rome, Italy

Oxidative stress has been suggested as a potential mechanism in the pathogenesis of chronic obstructive pulmonary disease (COPD). It has been difficult to address this hypothesis because of the limitations of conventional indices of lipid peroxidation in vivo. F2-isoprostanes (iPs) are prostaglandin isomers formed by free radical dependent peroxidation of arachidonic acid. Urinary iPF2alpha -III is a relatively abundant iPs produced in humans. In the present study, we investigated whether COPD is associated with enhanced oxidative stress by measuring urinary levels of this compound. Urinary excretion of iPF2alpha -III was determined in 38 patients with COPD and 30 sex- and age-matched healthy control subjects. Levels of iPF2alpha -III were significantly higher in patients with COPD (median, 84 pmol/ mmol creatinine; range, 38 to 321) than in healthy controls (median, 35.5 pmol/mmol creatinine; range, 15 to 65) (p < 0.0001). This elevation was independent of age, sex, smoking history, or duration of the disease. An inverse relationship was observed with the level of PaO2 (r = -0.38, p = 0.019). Aspirin treatment failed to decrease urinary levels of iPF2alpha -III (102 ± 8 versus 99.2 ± 7.3 pmol/ mmol creatinine), whereas 11-dehydro TxB2 was significantly reduced (695 ± 74 versus 95 ± 10 pmol/mmol creatinine) (p < 0.0001). Elevated levels of iPF2alpha -III (median, 125 pmol/mmol creatinine; range, 110 to 170) in five patients with COPD declined (median, 90 pmol/mmol creatinine; range, 70 to 110) (p < 0.001) as an acute exacerbation in their clinical condition resolved. Increased urinary iPF2alpha -III is consistent with the hypothesis that oxidative stress occurs in COPD. This provides a basis for dose finding and evaluation of antioxidant therapy in the treatment of this disease.




This article has been cited by other articles:


Home page
 Eur Respir JHome page
L. M. Fabbri, F. Luppi, B. Beghe, and K. F. Rabe
Complex chronic comorbidities of COPD
Eur. Respir. J., January 1, 2008; 31(1): 204 - 212.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
V. Seto, C. Hirota, S. Hirota, and L. J. Janssen
E-Ring Isoprostanes Stimulate a Cl Conductance in Airway Epithelium via Prostaglandin E2-Selective Prostanoid Receptors
Am. J. Respir. Cell Mol. Biol., January 1, 2008; 38(1): 88 - 94.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
C. Paredes, T. Tazzeo, and L. J. Janssen
E-Ring Isoprostane Augments Cholinergic Neurotransmission in Bovine Trachealis via FP Prostanoid Receptors
Am. J. Respir. Cell Mol. Biol., December 1, 2007; 37(6): 739 - 747.
[Abstract] [Full Text] [PDF]

Home page
 J. Gerontol. A Biol. Sci. Med. Sci.Home page
F. L. Fimognari, P. Pasqualetti, L. Moro, A. Franco, G. Piccirillo, R. Pastorelli, P. M. Rossini, and R. A. Incalzi
The Association Between Metabolic Syndrome and Restrictive Ventilatory Dysfunction in Older Persons
J. Gerontol. A Biol. Sci. Med. Sci., July 1, 2007; 62(7): 760 - 765.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
C. Liu, T. Tazzeo, and L. J. Janssen
Isoprostane-induced airway hyperresponsiveness is dependent on internal Ca2+ handling and Rho/ROCK signaling
Am J Physiol Lung Cell Mol Physiol, December 1, 2006; 291(6): L1177 - L1184.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
K Nagai, T Betsuyaku, T Kondo, Y Nasuhara, and M Nishimura
Long term smoking with age builds up excessive oxidative stress in bronchoalveolar lavage fluid
Thorax, June 1, 2006; 61(6): 496 - 502.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
K. Juul, A. Tybjaerg-Hansen, S. Marklund, P. Lange, and B. G. Nordestgaard
Genetically Increased Antioxidative Protection and Decreased Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., April 15, 2006; 173(8): 858 - 864.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
I. C. Allen, J. M. Hartney, T. M. Coffman, R. B. Penn, J. Wess, and B. H. Koller
Thromboxane A2 induces airway constriction through an M3 muscarinic acetylcholine receptor-dependent mechanism
Am J Physiol Lung Cell Mol Physiol, March 1, 2006; 290(3): L526 - L533.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
V. Cavalca, E. Sisillo, F. Veglia, E. Tremoli, G. Cighetti, L. Salvi, A. Sola, L. Mussoni, P. Biglioli, G. Folco, et al.
Isoprostanes and Oxidative Stress in Off-Pump and On-Pump Coronary Bypass Surgery
Ann. Thorac. Surg., February 1, 2006; 81(2): 562 - 567.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
A. G. N. Agusti
Systemic Effects of Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, November 1, 2005; 2(4): 367 - 370.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
C. A. Owen
Proteinases and Oxidants as Targets in the Treatment of Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, November 1, 2005; 2(4): 373 - 385.
[Abstract] [Full Text] [PDF]

Home page
 ERRHome page
W. MacNee
Treatment of stable COPD: antioxidants
Eur. Respir. Rev., September 1, 2005; 14(94): 12 - 22.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
P. Santus, A. Sola, P. Carlucci, F. Fumagalli, A. Di Gennaro, M. Mondoni, C. Carnini, S. Centanni, and A. Sala
Lipid Peroxidation and 5-Lipoxygenase Activity in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., April 15, 2005; 171(8): 838 - 843.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
E. F. M. Wouters
Local and Systemic Inflammation in Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, April 1, 2005; 2(1): 26 - 33.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
W. MacNee
Pulmonary and Systemic Oxidant/Antioxidant Imbalance in Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, April 1, 2005; 2(1): 50 - 60.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
L. G. Wood, M. L. Garg, J. L. Simpson, T. A. Mori, K. D. Croft, P. A. B. Wark, and P. G. Gibson
Induced Sputum 8-Isoprostane Concentrations in Inflammatory Airway Diseases
Am. J. Respir. Crit. Care Med., March 1, 2005; 171(5): 426 - 430.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
P. MONTUSCHI, P. J. BARNES, and L. J. ROBERTS II
Isoprostanes: markers and mediators of oxidative stress
FASEB J, December 1, 2004; 18(15): 1791 - 1800.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
P. J. Barnes
Mediators of Chronic Obstructive Pulmonary Disease
Pharmacol. Rev., December 1, 2004; 56(4): 515 - 548.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. Catalli and L. J. Janssen
Augmentation of bovine airway smooth muscle responsiveness to carbachol, KCl, and histamine by the isoprostane 8-iso-PGE2
Am J Physiol Lung Cell Mol Physiol, November 1, 2004; 287(5): L1035 - L1041.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
A.W. Boots, G.R.M.M. Haenen, and A. Bast
Oxidant metabolism in chronic obstructive pulmonary disease
Eur. Respir. J., November 2, 2003; 22(46_suppl): 14S - 27s.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
P.J. Barnes, S.D. Shapiro, and R.A. Pauwels
Chronic obstructive pulmonary disease: molecular and cellularmechanisms
Eur. Respir. J., October 1, 2003; 22(4): 672 - 688.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
G. E. Carpagnano, S. A. Kharitonov, O. Resta, M. P. Foschino-Barbaro, E. Gramiccioni, and P. J. Barnes
8-Isoprostane, a Marker of Oxidative Stress, Is Increased in Exhaled Breath Condensate of Patients With Obstructive Sleep Apnea After Night and Is Reduced by Continuous Positive Airway Pressure Therapy
Chest, October 1, 2003; 124(4): 1386 - 1392.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
L. K Heilbronn and E. Ravussin
Calorie restriction and aging: review of the literature and implications for studies in humans
Am. J. Clinical Nutrition, September 1, 2003; 78(3): 361 - 369.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
C. Sanchez-Moreno, M. P. Cano, B. de Ancos, L. Plaza, B. Olmedilla, F. Granado, and A. Martin
High-Pressurized Orange Juice Consumption Affects Plasma Vitamin C, Antioxidative Status and Inflammatory Markers in Healthy Humans
J. Nutr., July 1, 2003; 133(7): 2204 - 2209.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. Corradi, I. Rubinstein, R. Andreoli, P. Manini, A. Caglieri, D. Poli, R. Alinovi, and A. Mutti
Aldehydes in Exhaled Breath Condensate of Patients with Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., May 15, 2003; 167(10): 1380 - 1386.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
W A Biernacki, S A Kharitonov, and P J Barnes
Increased leukotriene B4 and 8-isoprostane in exhaled breath condensate of patients with exacerbations of COPD
Thorax, April 1, 2003; 58(4): 294 - 298.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
A.G.N. Agusti, A. Noguera, J. Sauleda, E. Sala, J. Pons, and X. Busquets
Systemic effects of chronic obstructive pulmonary disease
Eur. Respir. J., February 1, 2003; 21(2): 347 - 360.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
L.G. Wood, P.G. Gibson, and M.L. Garg
Biomarkers of lipid peroxidation, airway inflammation and asthma
Eur. Respir. J., January 1, 2003; 21(1): 177 - 186.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
J. D. Morrow and L. J. Roberts
The Isoprostanes: Their Role as an Index of Oxidant Stress Status in Human Pulmonary Disease
Am. J. Respir. Crit. Care Med., December 15, 2002; 166(12): S25 - 30.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
R. P. Bowler and J. D. Crapo
Oxidative Stress in Airways: Is There a Role for Extracellular Superoxide Dismutase?
Am. J. Respir. Crit. Care Med., December 15, 2002; 166(12): S38 - 43.
[Abstract] [Full Text] [PDF]

Home page
 Am J Crit CareHome page
C. Goodyear-Bruch and J. D. Pierce
Oxidative Stress in Critically Ill Patients
Am. J. Crit. Care., November 1, 2002; 11(6): 543 - 551.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
A. Couillard, C. Koechlin, J.P. Cristol, A. Varray, and C. Prefaut
Evidence of local exercise-induced systemic oxidative stress in chronic obstructive pulmonary disease patients
Eur. Respir. J., November 1, 2002; 20(5): 1123 - 1129.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
F. Violi, L. Iuliano, and G. A. FitzGerald
Reply
J. Am. Coll. Cardiol., February 6, 2002; 39(3): 554 - 555.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
J.-L. CRACOWSKI, C. CRACOWSKI, G. BESSARD, J.-L. PEPIN, J. BESSARD, C. SCHWEBEL, F. STANKE-LABESQUE, and C. PISON
Increased Lipid Peroxidation in Patients with Pulmonary Hypertension
Am. J. Respir. Crit. Care Med., September 15, 2001; 164(6): 1038 - 1042.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
S. A. KHARITONOV and P. J. BARNES
Exhaled Markers of Pulmonary Disease
Am. J. Respir. Crit. Care Med., June 1, 2001; 163(7): 1693 - 1722.
[Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
L. J. Janssen
Isoprostanes: an overview and putative roles in pulmonary pathophysiology
Am J Physiol Lung Cell Mol Physiol, June 1, 2001; 280(6): L1067 - L1082.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
E. A. Meagher, O. P. Barry, J. A. Lawson, J. Rokach, and G. A. FitzGerald
Effects of Vitamin E on Lipid Peroxidation in Healthy Persons
JAMA, March 7, 2001; 285(9): 1178 - 1182.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
L. Fontana, C. Giagulli, P. Minuz, A. Lechi, and C. Laudanna
8-Iso-PGF2{{alpha}} Induces {beta}2-Integrin-Mediated Rapid Adhesion of Human Polymorphonuclear Neutrophils : A Link Between Oxidative Stress and Ischemia/Reperfusion Injury
Arterioscler. Thromb. Vasc. Biol., January 1, 2001; 21(1): 55 - 60.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
L. J. Janssen, M. Premji, S. Netherton, A. Catalli, G. Cox, S. Keshavjee, and D. J. Crankshaw
Excitatory and Inhibitory Actions of Isoprostanes in Human and Canine Airway Smooth Muscle
J. Pharmacol. Exp. Ther., November 1, 2000; 295(2): 506 - 511.
[Abstract] [Full Text]

Home page
 CirculationHome page
F. Visioli, C. Galli, E. Plasmati, S. Viappiani, A. Hernandez, C. Colombo, and A. Sala
Olive Phenol Hydroxytyrosol Prevents Passive Smoking-Induced Oxidative Stress
Circulation, October 31, 2000; 102(18): 2169 - 2171.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
P. MONTUSCHI, J. V. COLLINS, G. CIABATTONI, N. LAZZERI, M. CORRADI, S. A. KHARITONOV, and P. J. BARNES
Exhaled 8-Isoprostane as an In Vivo Biomarker of Lung Oxidative Stress in Patients with COPD and Healthy Smokers
Am. J. Respir. Crit. Care Med., September 1, 2000; 162(3): 1175 - 1177.
[Abstract] [Full Text]

Home page
 Cardiovasc ResHome page
A. Mezzetti, F. Cipollone, and F. Cuccurullo
Oxidative stress and cardiovascular complications in diabetes: isoprostanes as new markers on an old paradigm
Cardiovasc Res, August 18, 2000; 47(3): 475 - 488.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
P. PAREDI, S. A. KHARITONOV, D. LEAK, S. WARD, D. CRAMER, and P. J. BARNES
Exhaled Ethane, a Marker of Lipid Peroxidation, Is Elevated in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., August 1, 2000; 162(2): 369 - 373.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
P. J. Barnes
Chronic Obstructive Pulmonary Disease
N. Engl. J. Med., July 27, 2000; 343(4): 269 - 280.
[Full Text] [PDF]

Home page
 J. Lipid Res.Home page
B. Frey, R. Haupt, S. Alms, G. Holzmann, T. König, H. Kern, W. Kox, B. Rüstow, and M. Schlame
Increase in fragmented phosphatidylcholine in blood plasma by oxidative stress
J. Lipid Res., July 1, 2000; 41(7): 1145 - 1153.
[Abstract] [Full Text]

Home page
 ChestHome page
N. F. Voelkel and R. Tuder
COPD : Exacerbation
Chest, May 1, 2000; 117(5_suppl_2): 376S - 379S.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
W. MacNee
Oxidants/Antioxidants and COPD
Chest, May 1, 2000; 117(5_suppl_1): 303S - 317S.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
P. Montuschi, S. A Kharitonov, G. Ciabattoni, M. Corradi, L. van Rensen, D. M Geddes, M. E Hodson, and P. J Barnes
Exhaled 8-isoprostane as a new non-invasive biomarker of oxidative stress in cystic fibrosis
Thorax, March 1, 2000; 55(3): 205 - 209.
[Abstract] [Full Text]

Home page
 ChestHome page
P. J. Barnes
Mechanisms in COPD : Differences From Asthma
Chest, February 1, 2000; 117(2_suppl): 10S - 14S.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Burke, J. A. Lawson, E. A. Meagher, J. Rokach, and G. A. FitzGerald
Specific Analysis in Plasma and Urine of 2,3-Dinor-5,6-dihydro-isoprostane F2alpha -III, a Metabolite of Isoprostane F2alpha -III and an Oxidation Product of gamma -Linolenic Acid
J. Biol. Chem., January 28, 2000; 275(4): 2499 - 2504.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
R. DWORSKI, J. J. MURRAY, L. JACKSONROBERTS II, J. A. OATES, J. D. MORROW, L. FISHER, and J. R. SHELLER
Allergen-induced Synthesis of F2-Isoprostanes in Atopic Asthmatics . Evidence for Oxidant Stress
Am. J. Respir. Crit. Care Med., December 1, 1999; 160(6): 1947 - 1951.
[Abstract] [Full Text]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
I. Rahman and W. MacNee
Lung glutathione and oxidative stress: implications in cigarette smoke-induced airway disease
Am J Physiol Lung Cell Mol Physiol, December 1, 1999; 277(6): L1067 - L1088.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
W. MACNEE and I. RAHMAN
Oxidants and Antioxidants as Therapeutic Targets in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., November 1, 1999; 160(5): S58 - 65.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
P. J. BARNES
Novel Approaches and Targets for Treatment of Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., November 1, 1999; 160(5): S72 - 79.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. A. Lawson, J. Rokach, and G. A. FitzGerald
Isoprostanes: Formation, Analysis and Use As Indices of Lipid Peroxidation in Vivo
J. Biol. Chem., August 27, 1999; 274(35): 24441 - 24444.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 1998 American Thoracic Society